查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
家庭診斷市場策略與趨勢:各用途，各流通管道，各技術，各國預測 - 附市場分析和執行指南(2024年～2028年)
市場調查報告書
商品編碼
1505241

家庭診斷市場策略與趨勢:各用途，各流通管道，各技術，各國預測 - 附市場分析和執行指南(2024年～2028年)

Home Diagnostics Markets Strategies and Trends. Forecasts by Application by Channel by Technology and by Country. With Market Analysis and Executive Guides, 2024 to 2028
出版日期: | 出版商: Howe Sound Research | 英文 392 Pages | 商品交期: 最快1-2個工作天內

價格

本報告提供全球家庭診斷市場相關調查，提供市場概要，以及各用途，各流通管道，各技術，各國趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 市場指南

第2章 簡介和市場定義

  • 家庭診斷是什麼嗎
  • 家庭的檢驗- 診斷能放的安靜的革命
  • 自家公司vs.發送vs.公司內部
  • 市場定義
  • 應用市場區隔
  • 調查手法
  • 觀點:醫療保健和IVD產業

第3章 產業概要

第4章 市場趨勢

  • 成長促進因素
  • 阻礙成長的要素
  • 診斷技術開發

第5章 家庭診斷的最近趨勢

第6章 主要家庭診斷企業的簡介

  • 1DropDiagnostics
  • 23andME Inc.
  • Abbott Laboratories
  • Accel Diagnostics
  • ADT Biotech
  • Akonni Biosystems
  • AlphaBiolabs
  • Alveo Technologies
  • Anitoa
  • Applied BioCode
  • Atomo Diagnostics
  • Aureum Diagnostics
  • Aus Diagnostics
  • Becton, Dickinson and Company
  • Binx Health
  • Biocartis
  • BioFire Diagnostics(bioMerieux)
  • bioMerieux Diagnostics
  • Bio-Rad Laboratories, Inc
  • Bosch Healthcare Solutions GmbH
  • Cepheid(Danaher)
  • Cue Health
  • Curetis(OpGen)
  • DBS Systems
  • Detect
  • Diagenode Diagnostics(Hologic)
  • Diasorin S.p.A.
  • Domus Diagnostics
  • Ellume
  • Everywell
  • Genomadix
  • Getlabs
  • Grip Molecular Technologies
  • Healthy.io
  • Hologic
  • Inflammatix
  • Invetech
  • Iollo
  • J&J Innovative Medicine
  • Karius
  • Laboratory Corporation of America
  • Letsgetchecked
  • LightDeck Diagnostics
  • Lucira Health(Pfizer)
  • LumiraDx
  • Meep
  • MFB Fertility
  • myLabBox
  • NanoDx
  • Nanomix
  • OraSure Technologies
  • Oxford Nanopore Technologies
  • Panagene
  • Prenetics
  • Primerdesign(Novacyt)
  • Prominex
  • Proof Diagnostics
  • Qiagen
  • QuantuMDx
  • Quest Diagnostics
  • QuidelOrtho
  • Randox Toxicology
  • Roche Diagnostics
  • Salignostics
  • SD Biosensor
  • Seegene
  • Siemens Healthineers
  • T2 Biosystems
  • TestCard
  • Thermo Fisher Scientific
  • Thriva
  • Visby Medical
  • XCR Diagnostics
  • YourBio Health

第7章 全球市場規模

  • 家庭診斷的全球市場規模(各國)
  • 家庭診斷的全球市場規模(各用途)
  • 家庭診斷的全球市場規模(各流通管道)
  • 家庭診斷的全球市場規模(各技術)

第8章 各用途全球市場

  • 呼吸系統市場
  • STD市場
  • UTI市場
  • 妊娠市場
  • 排卵市場
  • DNA市場
  • 其他

第9章 各流通管道全球市場

  • 商店市場
  • 線上市場
  • 其他

第10章 各技術全球市場

  • 免疫檢測市場
  • 化學市場
  • 核酸市場
  • 其他

第11章 附錄

OVERVIEW:

Rapid at home testing opens up new market.

Genetic DTC testing led the way. Now diagnostic testing is moving directly to the consumer. New technology has changed the picture on how and where testing is done. This report explores the outlook for all manner of At Home Diagnostics. Find out where the action is and the learn about the players.

Exciting technical developments especially in the seesaw between different analytic technology, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication. Even newer technology is on the horizon.

The report has hundreds of pages of information.

The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Situation Analysis
  • 1.2. Guide for Executives and Marketing Staff
  • 1.3. Guide for Investment Analysts and Management Consultants

2. Introduction and Market Definition

  • 2.1. What are Home Diagnostics?
  • 2.2. Home Testing - the quiet revolution in diagnostics
  • 2.3. Self vs. Send vs. In House - Who knew?
    • 2.3.1. Self
    • 2.3.2. Send
    • 2.3.3. In-House
  • 2.4. Market Definition
    • 2.4.1. Retail vs. Wholesale
  • 2.5. Application Segments
    • 2.5.1. Channel Segments
    • 2.5.2. Technology Segments
    • 2.5.3. Currency
    • 2.5.4. Years
  • 2.6. Methodology
    • 2.6.1. Methodology
    • 2.6.2. Sources
    • 2.6.3. Authors
  • 2.7. Perspective: Healthcare and the IVD Industry
    • 2.7.1. Global Healthcare Spending
    • 2.7.2. Spending on Diagnostics
    • 2.7.3. Important Role of Insurance for Diagnostics

3. Industry Overview

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Instrumentation Supplier
    • 3.1.4. Chemical/Reagent Supplier
    • 3.1.5. Pathology Supplier
    • 3.1.6. Independent Clinical Laboratory
    • 3.1.7. Public National/regional Laboratory
    • 3.1.8. Hospital Laboratory
    • 3.1.9. Physicians Office Lab (POLS)
    • 3.1.10. Audit Body
    • 3.1.11. Certification Body
  • 3.2. Diagnostic Market Segments
    • 3.2.1. Traditional Market Segmentation
    • 3.2.2. Laboratory Focus and Segmentation
    • 3.2.3. Segmenting the Home Diagnostics Market
  • 3.3. Industry Structure
    • 3.3.1. Hospital Testing Share
    • 3.3.2. Economies of Scale
    • 3.3.3. Hospital vs. Central Lab
    • 3.3.4. Physician Office Lab's
      • 3.3.4.1. The Problem with POLS
    • 3.3.5. Physician's and Home Diagnostics
    • 3.3.6. Pharmacies and Home Diagnostics
      • 3.3.6.1. The Diagnostic Plight of Pharmacies - Trying to do good
      • 3.3.6.2. The Theranos Legacy

4. Market Trends

  • 4.1. Factors Driving Growth
    • 4.1.1. Privacy and Anonymity
    • 4.1.2. The Internet Effect
    • 4.1.3. Rapid Result
    • 4.1.4. The Wellness Movement
    • 4.1.5. The COVID-19 Impact
  • 4.2. Factors Limiting Growth
    • 4.2.1. Trust Factor
    • 4.2.2. Infectious Disease is Declining But...
    • 4.2.3. Wellness Hurts
    • 4.2.4. Economic Growth improves Living Standards
  • 4.3. Diagnostic Technology Development
    • 4.3.1. The Multiplex Paradigm Shift
    • 4.3.2. NAT vs. Lateral Flow
    • 4.3.3. The Unusual Role of GPS
    • 4.3.4. Self and Send Competition
    • 4.3.5. The Relationship to DTC Genetic
    • 4.3.6. The Relationship to TeleHealth
    • 4.3.7. Sample Collection - Who Knew?

5. Home Diagnostics Recent Developments

  • 5.1. Recent Developments - Importance and How to Use This Section
    • 5.1.1. Importance of These Developments
    • 5.1.2. How to Use This Section
  • 5.2. Watmind Get Two EUAs
  • 5.3. Capitainer, Life Genomics Partner on Self-Sampling Diagnostics
  • 5.4. MyGeneticScreen Home Test Launched
  • 5.5. Demand for OTC Self-Tests Tempered by Lack of Reimbursement
  • 5.6. DiaCarta OTC Fecal Occult Blood Test Receives FDA Approval
  • 5.7. LetsGetChecked Nabs FDA Authorization for Chlamydia, Gonorrhea Test
  • 5.8. DiagMetrics Developing Breath Assays
  • 5.9. Co-Diagnostics Awarded $2.3M for TB, HPV Tests
  • 5.10. POC Developers Nuclein and Minute Molecular Dx Merge
  • 5.11. ReadyGo Dx to Make MDx Testing a 'Snap'
  • 5.12. Altratech Enters POC Testing Space by Supplanting PCR
  • 5.13. Sherlock Biosciences to Acquire Sense Biodetection
  • 5.14. Scripps Research, Cue Health to Offer Home Based Test-to-Treat Program
  • 5.15. KSL Pulse Scientific to Distribute Home Molecular Test in Canada
  • 5.16. Juno Diagnostics Offers NIPT With At-Home Sample Collection
  • 5.17. Sherlock Biosciences Adds to Diagnostic Toolkit
  • 5.18. Morgan Health Invests in LetsGetChecked
  • 5.19. Prenetics ColoClear by Circle
  • 5.20. Detect to Roll Out Next-Gen Molecular Instrument
  • 5.21. Diagnostics for the Real World Third-Generation POC Platform
  • 5.22. Labcorp Partnering With Getlabs for Home Collection
  • 5.23. Salignostics Closes Funding Round
  • 5.24. Cue Health Targets DTC Market in 2022
  • 5.25. Grip Molecular Developing Home Respiratory Panel
  • 5.26. Mainz Biomed Developing Home ColoAlert Assay
  • 5.27. MFB Fertility Closes Series A Financing Round
  • 5.28. Continued Demand for SARS-CoV-2 Rapid Tests
  • 5.29. Rapid Covid-19 Test Results Risk Going Uncounted
  • 5.30. FDA Grants EUAs for Direct-to-Consumer Coronavirus Kit
  • 5.31. Researchers Develop 15-Minute PCR System
  • 5.32. Stanford Developing Low-Cost, At-Home, COVID-19 Saliva Test
  • 5.33. Lucira Health Files for $115M IPO
  • 5.34. Spectrum Solutions Gets CE Mark for Saliva Collection Devices

6. Profiles of Key Home Diagnostics Companies

  • 6.1 1DropDiagnostics
  • 6.2 23andME Inc.
  • 6.3. Abbott Laboratories
  • 6.4. Accel Diagnostics
  • 6.5. ADT Biotech
  • 6.6. Akonni Biosystems
  • 6.7. AlphaBiolabs
  • 6.8. Alveo Technologies
  • 6.9. Anitoa
  • 6.10. Applied BioCode
  • 6.11. Atomo Diagnostics
  • 6.12. Aureum Diagnostics
  • 6.13. Aus Diagnostics
  • 6.14. Becton, Dickinson and Company
  • 6.15. Binx Health
  • 6.16. Biocartis
  • 6.17. BioFire Diagnostics (bioMerieux)
  • 6.18. bioMerieux Diagnostics
  • 6.19. Bio-Rad Laboratories, Inc
  • 6.20. Bosch Healthcare Solutions GmbH
  • 6.21. Cepheid (Danaher)
  • 6.22. Cue Health
  • 6.23. Curetis (OpGen)
  • 6.24. DBS Systems
  • 6.25. Detect
  • 6.26. Diagenode Diagnostics (Hologic)
  • 6.27. Diasorin S.p.A.
  • 6.28. Domus Diagnostics
  • 6.29. Ellume
  • 6.30. Everywell
  • 6.31. Genomadix
  • 6.32. Getlabs
  • 6.33. Grip Molecular Technologies
  • 6.34. Healthy.io
  • 6.35. Hologic
  • 6.36. Inflammatix
  • 6.37. Invetech
  • 6.38. Iollo
  • 6.39. J&J Innovative Medicine
  • 6.40. Karius
  • 6.41. Laboratory Corporation of America
  • 6.42. Letsgetchecked
  • 6.43. LightDeck Diagnostics
  • 6.44. Lucira Health (Pfizer)
  • 6.45. LumiraDx
  • 6.46. Meep
  • 6.47. MFB Fertility
  • 6.48. myLabBox
  • 6.49. NanoDx
  • 6.50. Nanomix
  • 6.51. OraSure Technologies
  • 6.52. Oxford Nanopore Technologies
  • 6.53. Panagene
  • 6.54. Prenetics
  • 6.55. Primerdesign (Novacyt)
  • 6.56. Prominex
  • 6.57. Proof Diagnostics
  • 6.58. Qiagen
  • 6.59. QuantuMDx
  • 6.60. Quest Diagnostics
  • 6.61. QuidelOrtho
  • 6.62. Randox Toxicology
  • 6.63. Roche Diagnostics
  • 6.64. Salignostics
  • 6.65. SD Biosensor
  • 6.66. Seegene
  • 6.67. Siemens Healthineers
  • 6.68. T2 Biosystems
  • 6.69. TestCard
  • 6.70. Thermo Fisher Scientific
  • 6.71. Thriva
  • 6.72. Visby Medical
  • 6.73. XCR Diagnostics
  • 6.74. YourBio Health

7. Global Market Size

  • 7.1. Home Diagnostics Global Market Size by Country
    • 7.1.1. Home Diagnostics Global Market Size by Country Table
    • 7.1.2. Home Diagnostics Global Market Size by Country Chart
  • 7.2. Home Diagnostics Global Market Size by Application
    • 7.2.1. Home Diagnostics Global Market Size by Application Table
    • 7.2.2. Home Diagnostics Global Market Size by Application Share by Year
    • 7.2.3. Home Diagnostics Global Market Size by Application Base vs Final
    • 7.2.4. Home Diagnostics Global Market Size by Application Base Year
    • 7.2.5. Home Diagnostics Global Market Size by Application Final Year
    • 7.2.6. Home Diagnostics Global Market Size by Application Segment Growth
  • 7.3. Home Diagnostics Global Market Size by Channel
    • 7.3.1. Home Diagnostics Global Market Size by Channel Table
    • 7.3.2. Home Diagnostics Global Market Size by Channel Share by Year
    • 7.3.3. Home Diagnostics Global Market Size by Channel Base vs Final
    • 7.3.4. Home Diagnostics Global Market Size by Channel Base Year
    • 7.3.5. Home Diagnostics Global Market Size by Channel Final Year
    • 7.3.6. Home Diagnostics Global Market Size by Channel Segment Growth
  • 7.4. Home Diagnostics Global Market Size by Technology
    • 7.4.1. Home Diagnostics Global Market Size by Technology Table
    • 7.4.2. Home Diagnostics Global Market Size by Technology Share by Year
    • 7.4.3. Home Diagnostics Global Market Size by Technology Base vs Final
    • 7.4.4. Home Diagnostics Global Market Size by Technology Base Year
    • 7.4.5. Home Diagnostics Global Market Size by Technology Final Year
    • 7.4.6. Home Diagnostics Global Market Size by Technology Segment Growth

8. Global Market by Application

  • 8.1. Respiratory Market
    • 8.1.1. Respiratory Market by Country Table
    • 8.1.2. Respiratory Market Chart
  • 8.2. STD Market
    • 8.2.1. STD Market by Country Table
    • 8.2.2. STD Market Chart
  • 8.3. UTI Market
    • 8.3.1. UTI Market by Country Table
    • 8.3.2. UTI Market Chart
  • 8.4. Pregnancy Market
    • 8.4.1. Pregnancy Market by Country Table
    • 8.4.2. Pregnancy Market by Chart
  • 8.5. Ovulation Market
    • 8.5.1. Ovulation Market by Country Table
    • 8.5.2. Ovulation Market by Chart
  • 8.6. DNA Market
    • 8.6.1. DNA Market by Country Table
    • 8.6.2. DNA Market Chart
  • 8.7. Other Market
    • 8.7.1. Other Market by Country Table
    • 8.7.2. Other Market Chart

9. Global Market by Channel

  • 9.1. Store Market
    • 9.1.1. Store Market by Country Table
    • 9.1.2. Store Market Chart
  • 9.2. Online Market
    • 9.2.1. Online Market by Country Table
    • 9.2.2. Online Market Chart
  • 9.3. Other Channel Market
    • 9.3.1. Other Channel by Country Table
    • 9.3.2. Other Channel Market Chart

10. Global Market by Technology

  • 10.1. Immunoassay Market
    • 10.1.1. Immunoassay Market by Country Table
    • 10.1.2. Immunoassay Market Chart
  • 10.2. Chemistry Market
    • 10.2.1. Chemistry Market by Country Table
    • 10.2.2. Chemistry Market Chart
  • 10.3. Nucleic Acid Market
    • 10.3.1. Nucleic Acid Market by Country Table
    • 10.3.2. Nucleic Acid Market Chart
  • 10.4. Other Technology Market
    • 10.4.1. Other Technology Market by Country Table
    • 10.4.2. Other Technology Market Chart

11. Appendices

  • 11.1. United States Medicare System: Clinical Laboratory Fees Schedule
  • 11.2. The Most Used IVD Assays
  • 11.3. The Highest Grossing Assays

Table of Tables

  • Table 1: Application Segment Definitions
  • Table 2: Channel Segment Definitions
  • Table 3: Technology Segment Definitions
  • Table 4: Market Players by Type
  • Table 5: Clinical Laboratory Departments and Segments
  • Table 6: Laboratory Management Focus - Different Approaches
  • Table 7: Key Segmentation Variables Going Forward
  • Table 8: Possible Market Segments of HOME Market
  • Table 9: Five Factors Driving Growth
  • Table 10: Four Factors Limiting Growth
  • Table 11: Self vs. Send TAT
  • Table 12: Home Diagnostics Global Market by Country/Region
  • Table 13: Home Diagnostics Global Market by Application
  • Table 14: Home Diagnostics Global Market by Channel
  • Table 15: Home Diagnostics Global Market by Technology
  • Table 16: Respiratory by Country
  • Table 17: STD market by country
  • Table 18: UTI Market by country
  • Table 19: Pregnancy Market by country
  • Table 20: Ovulation Market by country
  • Table 21: DNA Market by country
  • Table 22: Other Market by country
  • Table 23: Store Market by Country
  • Table 24: Online market by country
  • Table 25: Other Channel Market by country
  • Table 26: Immunoassay by Country
  • Table 27: Chemistry Market by country
  • Table 28: Nucleic Acid Market by country
  • Table 29: Other Technology Market by country
  • Table 30: Clinical Lab Fee Schedule
  • Table 31: The Most Common Assays
  • Table 32: Largest Revenue Assays

Table of Figures

  • Figure 1: Standard Test Paradigm
  • Figure 2: The New Test Paradigm
  • Figure 3: Global Healthcare Spending
  • Figure 4: The Lab Test Pie
  • Figure 5: The Road to Diagnostics
  • Figure 6: Chart Death Rates and Infectious Disease Decline
  • Figure 6: The Multiplex Paradigm Shift
  • Figure 8: Market Size by Country - Key Countries
  • Figure 9: Chart of Global Market by Application by Year
  • Figure 10: Application Segment Shares Base vs Final
  • Figure 11: Application Share Base Year
  • Figure 12: Application Share Final Year
  • Figure 13: Application Segment Growth Rates
  • Figure 14: Chart of Global Market by Channel by Year
  • Figure 15: Channel Segment Shares Base vs Final
  • Figure 16: Channel Share Base Year
  • Figure 17: Channel Share Final Year
  • Figure 18: Channel Segment Growth Rates
  • Figure 19: Chart of Global Market by Technology by Year
  • Figure 20: Technology Segment Shares Base vs Final
  • Figure 21: Technology Share Base Year
  • Figure 22: Technology Share Final Year
  • Figure 23: Technology Segment Growth Rates
  • Figure 24: Chart - Respiratory Market Growth
  • Figure 25: Chart - STD Market Growth
  • Figure 26: Chart - UTI Market Growth
  • Figure 27: Chart - Pregnancy Market Growth
  • Figure 28: Chart - Ovulation Market Growth
  • Figure 29: Chart - DNA Market Growth
  • Figure 30: Chart - Other Market Growth
  • Figure 31: Chart - Store Market Growth
  • Figure 32: Chart - Online Market Growth
  • Figure 33: Chart - Other Channel Market Growth
  • Figure 34: Chart - Immunoassay Market Growth
  • Figure 35: Chart - Chemistry Market Growth
  • Figure 36: Chart - Nucleic Acid Market Growth
  • Figure 37: Chart - Other Technology Market Growth